News

A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral ...
Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the ...
Misconceptions about these vaccines stem from misunderstandings about how the immune system and vaccines work. So do they ...
NRTIs, or nucleoside reverse transcriptase inhibitors, are used to prevent the HIV virus from replicating inside the body. But Ambati and his team previously determined that the drugs can also ...
His contribution — which he embarked upon as he started his Utah-based lab — was elucidating the structure and functions of the HIV virus’s capsid protein. Sundquist focused on the capsid because he ...
"I was told I had a virus with no cure and between three and nine months to live." HIV activist Jonathan Blake believes he was one of, if not the first person to be diagnosed in Britain with human ...
Today, with medication, a person living with HIV can lead a long, healthy life and not pass on the virus to others. However, cuts to HIV treatment and prevention threaten to roll back this ...